Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_assertion type Assertion NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_head.
- NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_assertion description "[The aim of this study was to investigate prognostic value of excision repair cross-complementing 1 (ERCC1), BCL2-associated athanogene (BAG-1), the breast and ovarian cancer susceptibility gene 1 (BRCA1), ribonucleotide reductase subunit M1 (RRM1) and class III ?-tubulin (TUBB3) in patients with non-small cell lung cancer (NSCLC) who received platinum- based adjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_provenance.
- NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_assertion evidence source_evidence_literature NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_provenance.
- NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_assertion SIO_000772 22439756 NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_provenance.
- NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_assertion wasDerivedFrom befree-20140225 NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_provenance.
- NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_assertion wasGeneratedBy ECO_0000203 NP224157.RAtKXbVXfJ8aKz1qB4PEx5bYSI5ilhjg5NFRH25zlsHs4130_provenance.